sign in sign up
<<
Home , Duan (surname), Qiao (surname), Zhao (surname)

Name/Surname Fanghui , Professor

Affiliation Deputy Director and Professor of Department of Cancer Epidemiology, National Cancer Center, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of . IARC Host Group Screening Group (SCR), IARC, Dr Rengaswamy Sankaranarayanan. Speciality Cancer Epidemiology; Cancer Prevention and early detection Academic Degrees 2007-2010: Ph.D, Peking Union Medical College (PUMC), Beijing, The People's Republic of China. 1998-2001: M.P.H., Peking Union Medical College, Beijing, The People's Republic of China. 1993-1998: Medical Diploma, Norman Bethune University of Medical Sciences, Changchun, Jilin Province, China Programme at IARC Exploration of Appropriate Cervical Cancer Screening Program Models for China Selected Publications • H, XF, Zhao FH (Correspondence author), Garland SM, Bhatla N, Y L. Estimation of Cancer Burden Attributable to Infection in Asia. J Epidemiol. 2015 Nov 5;25(10):626-38. • FC, W, Hu YM, Hong Y, J, X, Zhang YJ, QJ, Zhao FH (Correspondence Author), JX, Zhang YS, X, Zhang CF, Tang H, Zhang H, Lebacq M, David MP, Datta SK, Struyf F, D, Descamps D. Efficacy, immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Chinese women aged 18-25 years: Results from a randomised controlled trial. Int J Cancer. 2014 Dec 1;135(11):2612-22. • Zhao FH, Zhu FC, Chen W, Li J, Hu YM, Hong Y, Zhang YJ, Pan QJ, Zhu JH, Zhang X, Chen Y, Tang H, Zhang H, Durand C, Datta SK, Struyf F, Bi D. Baseline prevalence and type distribution of human papillomavirus in healthy Chinese women aged 18-25 years enrolled in a clinical trial. Int J Cancer. 2014 Dec 1;135(11):2604-11. • Zhao FH, Jeronimo JA, Qiao YL, Schweizer J, Chen W, Valdez M, P, Zhang X, LN, Bansil P, Paul P, Mahoney C, Berard-Bergery M, P, Peck R, Li J, Chen F, Stoler MH, Castle PE. Evaluation of Novel, Lower- Cost Molecular Screening Tests for Human Papillomavirus in Rural China. Cancer Prev Res. 2013 Sep;6(9):938-48. • IJ, Huang R, W, Zhang SK, SM, Zhao FH(Correspondence author), Smith JS, Qiao YL. Effect of an educational intervention on HPV knowledge and vaccine attitudes among urban employed women and female undergraduate students in China: a cross-sectional study. BMC Public Health. 2013 Oct 2;13:916. • Zhang SK, Pan XF, Wang SM, Yang CX, XH, Wang ZZ, Li M, ZF, Zhao FH(Correspondence author), Qiao YL*. Perceptions and acceptability of HPV vaccination among parents of young adolescents: a multicenter national survey in China. Vaccine. 2013 Jul 11;31(32):3244-9. • Zhao FH, Lewkowitz AK, Hu SY, Chen F, Li LY, Zhang QM, RF, Li CQ, Wei LH, AD, Zhang WH, Pan QJ, Zhang X, Belinson JL, Sellors JW, Smith JS, Qiao YL, Franceschi S. Prevalence of HPV and cervical intraepithelial neoplasia in China: A pooled analysis of 17 population-based Studies. Int J Cancer. 2012 Dec 15;131(12):2929-38. • Zhao FH, Tiggelaar SM, Hu SY, Xu LN, Hong Y, Niyazi M, Gao XH, Ju LR, Zhang LQ, Feng XX, XZ, XL,Wang J, Yang Y, Li CQ, JH, Liu JH, Lu YB, Li L, Q, Liu JF, Zhao N, Schmidt JE, Qiao YL. A Multi- center Survey of Age of Sexual Debut and Sexual Behavior in Chinese Women: Suggestions for Optimal Age of HPV Vaccination in China. Cancer Epidemiology. 2012 36: 384– 390. • Zhao FH, Lewkowitz A, Chen F, MJ, Hu SY, Zhang X, Pan QJ, Li CQ, JF, Li SM, Smith JS, Belinson JL, Qiao YL, Castle PE. A pooled analysis of self-collected cervicovaginal specimen and HPV DNA testing performance as primary screening test for cervical cancer in rural China. J Natl Cancer Inst. 2012 Feb 8;104(3):178-88. (with commentary). • Zhao FH, Lin MJ, Chen F, Hu SY, Zhang R, Belinson JL, Sellors JW, Franceschi S, Qiao YL, Castle PE; on behalf of Cervical Cancer Screening Group in China. Performance of high-risk HPV DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population-based studies from China. Lancet Oncol. 2010 Dec;11(12):1160-1171 (Fast-track with commentary). • Zhao FH, Forman MR, Belinson J, Shen YH, Graubard BI, Patel AC, Rong SD, Pretorius RG, Qiao YL. Risk factors for HPV infection and cervical cancer among unscreened women in a high-risk rural area of China. Int J Cancer. 2006 Jan 15;118(2):442-8. • Castle PE, Zhao FH. Population Effectiveness, Not Efficacy, Should Decide Who Gets Vaccinated Against Human Papillomavirus via Publicly Funded Programs. Editorial commentary, the Journal of Infectious Diseases 2011;204:335–37.)

Short background Professor Zhao is Deputy Director and Professor at the Dept. of Cancer Epidemiology, Cancer Institute/Hospital, Chinese Academy of Medical Sciences (CICAMS). She is also the mentor of PhD students in Peking Union Medical College, the primary mentor for NIH Fogarty and Fulbright Scholars in China, as well as the mentor and initiator of Chicago University D & A China Bridge Fellowship Program in China.

Professor Zhao received her Medical Diploma from Norman Bethune University of Medical Sciences, her PhD degree in Epidemiology from Peking Union Medical College. She has worked as a visiting scholar during 2003-2004 and 2013-2014 in Division of Cancer Prevention and Control, Center for Global Health, Division of Cancer Epidemiology & Genetics at National Cancer Institute, National Institutes of Health (NCI/NIH).

Her research interests include Epidemiological research on cancers notably on cervical cancer and breast cancer; implementation and methodological research in screening and early detection of cancer; primary prevention and intervention to cancers; pubic health promotion and health policy

Over the past 18 years, Professor Zhao has been involved in a serial research in cervical cancer prevention including A) Etiology and epidemiologic research on human papillomavirus (HPV) and cervical cancer; B) Clinical trials on cervical cancer screening technologies and research on strategies; C) Cost- effectiveness and health economic analysis of strategies on cervical cancer screening; D) HPV Vaccine clinical trial and vaccines implementation studies. Her research findings have great scientific and practical significances for cervical cancer epidemiology, etiology and prevention in China.

Professor Zhao has received a dozen of research grants including the National Science Fund for Excellent Young Scholars; the National High-tech R&D Program of China (863 Program); the National Key Technology Research and Development Program of China during the 11th Five-Year Plan; and a grant from Bill and Melinda Gates Foundation as well. She has published more than 100 peer reviewed articles, monographs and book chapters in Chinese and English, some of them published on the Journals of ,and with high impact factors.

Professor Zhao serves as Research Committee Chair, Asia Oceania Research Organization on Genital Infections and Neoplasia (AOGIN); Secretary-general & Member of the Standing Committee of Cancer Epidemiology Committee, Chinese Anti-Cancer Association (CACA); Deputy Secretary- general & Member of the Standing Committee of Chinese Society of Colposcopy & Cervical Pathology (CSCCP) ; Member of Epidemiology Committee, Chinese Association of Preventive Medicine; Member of maternal and child health industry branch of the National Health Industry Enterprise Management Association; Member of the innovation alliance of young scientists in the Chinese Academy of Medical Sciences; Secretary of National Cervical Cancer Prevention Experts Committee, Ministry of Health, China.

Professor Zhao has the honor of national excellent doctoral dissertation, and also won several national scientific awards and international Scholarship awards including the Science and Technology Advanced Awards of Ministry of Education and Beijing Municipal Government; Higher Education Institutions Awards for Excellent Teachers; Chinese medical science and Technology Award; Science and technology award of Chinese Preventive Medicine Association, etc.

Institutional webpage: https://dce.cicams.ac.cn/EPI/en/content/fanghui-zhao

Personal webpage: http://www.aacr.com.cn/info.asp?call=39